These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4553158)

  • 1. Demonstration of basal cell immunofluorescence in drug-induced toxic epidermal necrolysis.
    Stein KM; Schlappner OL; Heaton CL; Decherd JW
    Br J Dermatol; 1972 Mar; 86(3):246-52. PubMed ID: 4553158
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffuse intraepidermal deposition of immunoreactants on direct immunofluorescence: a clue to the early diagnosis of epidermal necrolysis.
    King T; Helm TN; Valenzuela R; Bergfeld WF
    Int J Dermatol; 1994 Sep; 33(9):634-6. PubMed ID: 8002159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-dependent binding of circulating antibodies in drug-induced toxic epidermal necrolysis.
    Hensen EJ; Claas FH; Vermeer BJ
    Lancet; 1981 Jul; 2(8238):151-2. PubMed ID: 6113511
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxic epidermal necrolysis in a patient affected by mixed essential cryoglobulinemia.
    Solinas A; Cottoni F; Tanda F; Tocco A
    J Am Acad Dermatol; 1988 May; 18(5 Pt 2):1165-9. PubMed ID: 3372779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic epidermal necrolysis.
    Ammann AJ; Tooley WH; Hong R
    Lancet; 1972 Sep; 2(7775):484-5. PubMed ID: 4115367
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clues to pathogenesis of toxic epidermal necrolysis.
    Merot Y; Saurat JH
    Int J Dermatol; 1985 Apr; 24(3):165-8. PubMed ID: 3888879
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxic epidermal necrolysis following chlorpromazine ingestion complicated by SIADH.
    Purcell P; Valmana A
    Postgrad Med J; 1996 Mar; 72(845):186. PubMed ID: 8731716
    [No Abstract]   [Full Text] [Related]  

  • 9. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Eginli A; Shah K; Watkins C; Krishnaswamy G
    Ann Allergy Asthma Immunol; 2017 Feb; 118(2):143-147. PubMed ID: 28153080
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxic epidermal necrolysis: examining a multifaceted enigma.
    Binnick SA; Pirozzi DJ
    Postgrad Med; 1975 Oct; 58(4):126-30. PubMed ID: 1099565
    [No Abstract]   [Full Text] [Related]  

  • 12. [Systemic lupus erythematosus presenting as Stevens-Johnson syndrome].
    Bellakhal S; Ben Kaab B; Teyeb Z; Souissi A; Derbel F; Douggui MH
    Pathol Biol (Paris); 2015 Sep; 63(4-5):222-3. PubMed ID: 26088436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological properties in staphylococcal toxic epidermal necrolysis.
    Sarai Y; Nakahara H; Ishikawa T; Kondo I; Futaki S; Ichizawa Y; Hirayama K
    Dermatologica; 1977; 155(5):315-8. PubMed ID: 902844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced toxic epidermal necrolysis.
    Heng MC
    Br J Dermatol; 1985 Nov; 113(5):597-600. PubMed ID: 4063192
    [No Abstract]   [Full Text] [Related]  

  • 15. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.
    Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H
    Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.